Pogge, ThomasGrootendorst, PaulHollis, AidanLevine, David K.Edwards, Aled M.2015-12-101488-2329http://hdl.handle.net/1885/57624Keywords: counterfeit drug; drug; generic drug; new drug; unclassified drug; article; Canada; commercial phenomena; competition; confidentiality; drug efficacy; drug industry; drug information; drug manufacture; drug marketing; drug research; drug safety; financial201110.1503/cmaj.1003752016-06-14